Registration Strip Icon for charts 실시간 차트, 분석 도구 및 가격을 받으려면 등록하세요.

MBIO

Mustang Bio (MBIO)

Mustang Bio Inc
일자:
정렬 기준:
 검색 관련기사 보기:NASDAQ:MBIO
일자시간출처헤드라인심볼기업
2024/06/1313:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:MBIOMustang Bio Inc
2024/06/0706:00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:MBIOMustang Bio Inc
2024/06/0509:35Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:MBIOMustang Bio Inc
2024/06/0509:33Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:MBIOMustang Bio Inc
2024/06/0106:09Edgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:MBIOMustang Bio Inc
2024/05/2205:15Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:MBIOMustang Bio Inc
2024/05/1319:01Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:MBIOMustang Bio Inc
2024/05/0305:01GlobeNewswire Inc.Mustang Bio Announces Closing of $4 Million Public OfferingNASDAQ:MBIOMustang Bio Inc
2024/04/3009:00GlobeNewswire Inc.Mustang Bio Announces Pricing of $4 Million Public OfferingNASDAQ:MBIOMustang Bio Inc
2024/03/2822:00GlobeNewswire Inc.Mustang Bio Announces Vision for CAR T-Cell Therapy Platform Expansion into Autoimmune DiseasesNASDAQ:MBIOMustang Bio Inc
2024/03/1205:30Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:MBIOMustang Bio Inc
2024/03/1205:05GlobeNewswire Inc.Mustang Bio Reports Full-Year 2023 Financial Results and Recent Corporate HighlightsNASDAQ:MBIOMustang Bio Inc
2024/03/1205:02Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:MBIOMustang Bio Inc
2024/03/0721:30GlobeNewswire Inc.Mustang Bio Announces Publication in Nature Medicine of Data from Phase 1 Trial Evaluating MB-101 IL13Rα2-targeted CAR T-Cells in High-Grade GliomaNASDAQ:MBIOMustang Bio Inc
2024/02/1506:15Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:MBIOMustang Bio Inc
2024/01/2606:07Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:MBIOMustang Bio Inc
2024/01/1122:30GlobeNewswire Inc.Mustang Bio to Participate in the B. Riley Securities 4th Annual Oncology ConferenceNASDAQ:MBIOMustang Bio Inc
2024/01/0506:05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:MBIOMustang Bio Inc
2023/12/2006:06Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:MBIOMustang Bio Inc
2023/12/1211:52Edgar (US Regulatory)Form S-1 - General form for registration of securities under the Securities Act of 1933NASDAQ:MBIOMustang Bio Inc
2023/12/1122:37Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:MBIOMustang Bio Inc
2023/12/1122:30GlobeNewswire Inc.Mustang Bio Presents Updated Phase 1/2 Multicenter Clinical Data for MB-106 at the 2023 American Society of Hematology (ASH) Annual MeetingNASDAQ:MBIOMustang Bio Inc
2023/11/1506:44Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:MBIOMustang Bio Inc
2023/11/1506:05GlobeNewswire Inc.Mustang Bio Reports Third Quarter 2023 Financial Results and Recent Corporate HighlightsNASDAQ:MBIOMustang Bio Inc
2023/11/0404:22Edgar (US Regulatory)Form D - Notice of Exempt Offering of SecuritiesNASDAQ:MBIOMustang Bio Inc
2023/11/0305:05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:MBIOMustang Bio Inc
2023/11/0222:28GlobeNewswire Inc.Mustang Bio Announces MB-106 CD20-Targeted CAR-T Data Selected for Presentation at 65th American Society of Hematology (ASH) Annual MeetingNASDAQ:MBIOMustang Bio Inc
2023/10/3103:57Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:MBIOMustang Bio Inc
2023/10/3103:15GlobeNewswire Inc.Mustang Bio Announces Closing of $4.4 Million Registered Direct Offering Priced At-the-Market Under Nasdaq RulesNASDAQ:MBIOMustang Bio Inc
2023/10/3023:30Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:MBIOMustang Bio Inc
 검색 관련기사 보기:NASDAQ:MBIO